Patterns of treatment of patients with prostate cancer initially managed with surveillance: Results from the CaPSURE database

Theresa Koppie, Gary D. Grossfeld, David Miller, Jenny Yu, David Stier, Jeanette M. Broering, Deborah Lubeck, James M. Henning, Scott C. Flanders, Peter R. Carroll

Research output: Contribution to journalArticle

74 Citations (Scopus)

Abstract

Purpose: We determined the demographic and clinical profile of men who elect surveillance as the initial management of prostate cancer as well as the incidence and predictors of secondary treatment of these patients. Materials and Methods: The Cancer of the Prostate Strategic Urological Research Endeavor (CaPSURE) is a national disease registry of patients with various stages and treatments of prostate cancer. Using this database of 4,458 men we identified 329 (8.2%) who elected surveillance as the initial management of prostate cancer. Patients choosing watchful waiting were compared to other CaPSURE participants using the chi-square test. The likelihood of treatment initiation in the watchful waiting group was calculated using the Kaplan-Meier method. After adjusting for patient age, race, prostate specific antigen (PSA) at diagnosis, clinical T stage and total Gleason score the Cox proportional hazards regression model was used to determine significant predictors of treatment initiation. Results: Compared with others in the database, patients on watchful waiting were more likely to be 75 years old or older (51% versus 16%, p

Original languageEnglish (US)
Pages (from-to)81-88
Number of pages8
JournalJournal of Urology
Volume164
Issue number1
StatePublished - Jul 2000
Externally publishedYes

Fingerprint

Watchful Waiting
Prostatic Neoplasms
Databases
Research
Therapeutics
Neoplasm Grading
Chi-Square Distribution
Prostate-Specific Antigen
Proportional Hazards Models
Registries
Demography
Incidence

Keywords

  • Prostate
  • Prostate-specific antigen
  • Prostatic neoplasms

ASJC Scopus subject areas

  • Urology

Cite this

Koppie, T., Grossfeld, G. D., Miller, D., Yu, J., Stier, D., Broering, J. M., ... Carroll, P. R. (2000). Patterns of treatment of patients with prostate cancer initially managed with surveillance: Results from the CaPSURE database. Journal of Urology, 164(1), 81-88.

Patterns of treatment of patients with prostate cancer initially managed with surveillance : Results from the CaPSURE database. / Koppie, Theresa; Grossfeld, Gary D.; Miller, David; Yu, Jenny; Stier, David; Broering, Jeanette M.; Lubeck, Deborah; Henning, James M.; Flanders, Scott C.; Carroll, Peter R.

In: Journal of Urology, Vol. 164, No. 1, 07.2000, p. 81-88.

Research output: Contribution to journalArticle

Koppie, T, Grossfeld, GD, Miller, D, Yu, J, Stier, D, Broering, JM, Lubeck, D, Henning, JM, Flanders, SC & Carroll, PR 2000, 'Patterns of treatment of patients with prostate cancer initially managed with surveillance: Results from the CaPSURE database', Journal of Urology, vol. 164, no. 1, pp. 81-88.
Koppie, Theresa ; Grossfeld, Gary D. ; Miller, David ; Yu, Jenny ; Stier, David ; Broering, Jeanette M. ; Lubeck, Deborah ; Henning, James M. ; Flanders, Scott C. ; Carroll, Peter R. / Patterns of treatment of patients with prostate cancer initially managed with surveillance : Results from the CaPSURE database. In: Journal of Urology. 2000 ; Vol. 164, No. 1. pp. 81-88.
@article{ff18ca542acc40e0810a437601ec5449,
title = "Patterns of treatment of patients with prostate cancer initially managed with surveillance: Results from the CaPSURE database",
abstract = "Purpose: We determined the demographic and clinical profile of men who elect surveillance as the initial management of prostate cancer as well as the incidence and predictors of secondary treatment of these patients. Materials and Methods: The Cancer of the Prostate Strategic Urological Research Endeavor (CaPSURE) is a national disease registry of patients with various stages and treatments of prostate cancer. Using this database of 4,458 men we identified 329 (8.2{\%}) who elected surveillance as the initial management of prostate cancer. Patients choosing watchful waiting were compared to other CaPSURE participants using the chi-square test. The likelihood of treatment initiation in the watchful waiting group was calculated using the Kaplan-Meier method. After adjusting for patient age, race, prostate specific antigen (PSA) at diagnosis, clinical T stage and total Gleason score the Cox proportional hazards regression model was used to determine significant predictors of treatment initiation. Results: Compared with others in the database, patients on watchful waiting were more likely to be 75 years old or older (51{\%} versus 16{\%}, p",
keywords = "Prostate, Prostate-specific antigen, Prostatic neoplasms",
author = "Theresa Koppie and Grossfeld, {Gary D.} and David Miller and Jenny Yu and David Stier and Broering, {Jeanette M.} and Deborah Lubeck and Henning, {James M.} and Flanders, {Scott C.} and Carroll, {Peter R.}",
year = "2000",
month = "7",
language = "English (US)",
volume = "164",
pages = "81--88",
journal = "Journal of Urology",
issn = "0022-5347",
publisher = "Elsevier Inc.",
number = "1",

}

TY - JOUR

T1 - Patterns of treatment of patients with prostate cancer initially managed with surveillance

T2 - Results from the CaPSURE database

AU - Koppie, Theresa

AU - Grossfeld, Gary D.

AU - Miller, David

AU - Yu, Jenny

AU - Stier, David

AU - Broering, Jeanette M.

AU - Lubeck, Deborah

AU - Henning, James M.

AU - Flanders, Scott C.

AU - Carroll, Peter R.

PY - 2000/7

Y1 - 2000/7

N2 - Purpose: We determined the demographic and clinical profile of men who elect surveillance as the initial management of prostate cancer as well as the incidence and predictors of secondary treatment of these patients. Materials and Methods: The Cancer of the Prostate Strategic Urological Research Endeavor (CaPSURE) is a national disease registry of patients with various stages and treatments of prostate cancer. Using this database of 4,458 men we identified 329 (8.2%) who elected surveillance as the initial management of prostate cancer. Patients choosing watchful waiting were compared to other CaPSURE participants using the chi-square test. The likelihood of treatment initiation in the watchful waiting group was calculated using the Kaplan-Meier method. After adjusting for patient age, race, prostate specific antigen (PSA) at diagnosis, clinical T stage and total Gleason score the Cox proportional hazards regression model was used to determine significant predictors of treatment initiation. Results: Compared with others in the database, patients on watchful waiting were more likely to be 75 years old or older (51% versus 16%, p

AB - Purpose: We determined the demographic and clinical profile of men who elect surveillance as the initial management of prostate cancer as well as the incidence and predictors of secondary treatment of these patients. Materials and Methods: The Cancer of the Prostate Strategic Urological Research Endeavor (CaPSURE) is a national disease registry of patients with various stages and treatments of prostate cancer. Using this database of 4,458 men we identified 329 (8.2%) who elected surveillance as the initial management of prostate cancer. Patients choosing watchful waiting were compared to other CaPSURE participants using the chi-square test. The likelihood of treatment initiation in the watchful waiting group was calculated using the Kaplan-Meier method. After adjusting for patient age, race, prostate specific antigen (PSA) at diagnosis, clinical T stage and total Gleason score the Cox proportional hazards regression model was used to determine significant predictors of treatment initiation. Results: Compared with others in the database, patients on watchful waiting were more likely to be 75 years old or older (51% versus 16%, p

KW - Prostate

KW - Prostate-specific antigen

KW - Prostatic neoplasms

UR - http://www.scopus.com/inward/record.url?scp=0033921106&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0033921106&partnerID=8YFLogxK

M3 - Article

C2 - 10840429

AN - SCOPUS:0033921106

VL - 164

SP - 81

EP - 88

JO - Journal of Urology

JF - Journal of Urology

SN - 0022-5347

IS - 1

ER -